A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

por Houba, P H J, Boven, E, Meulen-Muileman, I H van der, Leenders, R G G, Scheeren, J W, Pinedo, H M, Haisma, H J
Publicado 2001